DaVita Pre-Tax Profit Margin 2010-2024 | DVA

Current and historical pre-tax profit margin for DaVita (DVA) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. DaVita pre-tax profit margin for the three months ending March 31, 2024 was .
DaVita Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-03-31 $12.34B $1.33B 10.81%
2023-12-31 $12.14B $1.18B 9.70%
2023-09-30 $11.91B $1.04B 8.69%
2023-06-30 $11.74B $0.86B 7.36%
2023-03-31 $11.67B $0.92B 7.87%
2022-12-31 $11.61B $0.97B 8.32%
2022-09-30 $11.64B $1.13B 9.74%
2022-06-30 $11.63B $1.32B 11.36%
2022-03-31 $11.62B $1.40B 12.09%
2021-12-31 $11.62B $1.52B 13.06%
2021-09-30 $11.58B $1.53B 13.21%
2021-06-30 $11.57B $1.42B 12.27%
2021-03-31 $11.53B $1.33B 11.49%
2020-12-31 $11.55B $1.32B 11.40%
2020-09-30 $11.54B $1.37B 11.88%
2020-06-30 $11.52B $1.36B 11.83%
2020-03-31 $11.49B $1.35B 11.74%
2019-12-31 $11.39B $1.20B 10.50%
2019-09-30 $11.31B $1.07B 9.49%
2019-06-30 $11.25B $0.97B 8.58%
2019-03-31 $11.30B $0.96B 8.51%
2018-12-31 $11.40B $1.05B 9.19%
2018-09-30 $11.36B $0.84B 7.36%
2018-06-30 $11.28B $0.96B 8.49%
2018-03-31 $11.09B $0.93B 8.35%
2017-12-31 $10.88B $1.40B 12.87%
2017-09-30 $7.77B $1.77B 22.71%
2017-06-30 $8.74B $2.19B 25.08%
2017-03-31 $9.76B $2.13B 21.86%
2016-12-31 $10.71B $1.62B 15.15%
2016-09-30 $10.76B $1.32B 12.28%
2016-06-30 $10.56B $1.01B 9.60%
2016-03-31 $10.28B $1.12B 10.86%
2015-12-31 $9.98B $0.69B 6.90%
2015-09-30 $13.58B $0.93B 6.86%
2015-06-30 $13.30B $0.86B 6.46%
2015-03-31 $13.04B $0.81B 6.21%
2014-12-31 $12.80B $1.31B 10.23%
2014-09-30 $12.53B $1.34B 10.65%
2014-06-30 $12.28B $1.27B 10.34%
2014-03-31 $11.98B $1.40B 11.70%
2013-12-31 $11.77B $1.13B 9.57%
2013-09-30 $11.18B $1.03B 9.19%
2013-06-30 $10.13B $1.03B 10.15%
2013-03-31 $9.17B $0.80B 8.75%
2012-12-31 $8.19B $1.00B 12.23%
2012-09-30 $7.46B $1.01B 13.57%
2012-06-30 $7.27B $1.00B 13.75%
2012-03-31 $7.02B $1.00B 14.25%
2011-12-31 $6.73B $0.92B 13.62%
2011-09-30 $6.41B $0.75B 11.76%
2011-06-30 $6.30B $0.71B 11.31%
2011-03-31 $6.22B $0.72B 11.57%
2010-12-31 $6.22B $0.74B 11.91%
2010-09-30 $6.36B $0.81B 12.68%
2010-06-30 $6.28B $0.79B 12.55%
2010-03-31 $6.21B $0.78B 12.60%
2009-12-31 $6.10B $0.76B 12.41%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.150B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.537B 10.61
Quest Diagnostics (DGX) United States $15.695B 16.22
Encompass Health (EHC) United States $8.507B 21.78
Chemed (CHE) United States $8.408B 26.06
Elanco Animal Health (ELAN) United States $8.297B 21.53
Option Care Health (OPCH) United States $5.048B 19.11
RadNet (RDNT) United States $4.325B 90.06
Amedisys (AMED) United States $3.145B 22.28
Astrana Health (ASTH) United States $2.239B 30.28
LifeStance Health (LFST) United States $2.179B 0.00
Addus HomeCare (ADUS) United States $1.827B 26.14
U.S Physical Therapy (USPH) United States $1.534B 41.06
Pennant (PNTG) United States $0.706B 37.29
Aveanna Healthcare Holdings (AVAH) United States $0.539B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00